期刊文献+

超声引导下经皮微波消融与CT超声引导下肿瘤射频消融治疗原发性肝癌的临床比较 被引量:48

Clinical Comparison of Ultrasound-guided Percutaneous Microwave Ablation and CT Ultrasound-guided Radiofrequency Ablation in Treating Primary Liver Cancer
在线阅读 下载PDF
导出
摘要 目的探讨超声引导下经皮微波消融与CT超声引导下肿瘤射频消融治疗原发性肝癌的临床比较。方法选取2009年2月-2013年3月我院微创介入治疗科收治的46例(72个病灶)原发性肝癌患者为研究对象,随机数字表法均分为研究组和对照组,对照组行超声引导下经皮微波消融治疗,研究组行CT超声引导下肿瘤射频消融治疗,观察两组围术期相关指标[手术时间、术后住院时间、住院费用],消融情况[消融点数、消融时间]、临床疗效影像学评价、3年随访复发率。结果研究组手术时间、术后住院时间分别均较对照组显著短(P<0.05),两组住院费用相较无显著差异(P>0.05);两组术后病灶均较好地清除;研究组3年复发率较对照组显著低,差异具有统计学意义(χ2=5.254,P<0.05)。结论超声引导下经皮微波消融与CT超声引导下肿瘤射频消融对原发性肝癌的临床疗效均显著,射频消融在手术时间、住院时间、消融时间、3年复发率方面均具有更显著优势,值得临床推广应用。 Objective Tocompare the effects between ultrasound-guided percutaneous microwave ablation and CT ultrasound-guided radiofrequency ablation in treating primary liver cancer. Methods Forty-six patients(72 lesions) with primary liver cancer treated by minimal invasive interventional therapy in our hospital between February 2009 and March 2013 were selected as study subjects and were equally divided into study group and control group by the random number table method. The control group received ultrasound-guided percutaneous microwave ablation while study group received CT ultrasound-guided radiofrequency ablation. The related perioperative indexes(operation time, postoperative length of stay, hospitalization expenses), state of ablation(ablation count, duration of ablation), imaging evaluation of clinical efficacy, 3 year follow-up recurrence rate in the two groups were observed. Results Operation time and postoperative length of stay of study group were significantly shorter than control group(P〈0.05). There was no significant difference in hospitalization expenses between the two groups(P〉0.05), after operation, lesions in both groups were effectively removed. The 3-year recurrence rate in study group was significantly lower than control group(χ2=5.254, P〈0.05). Conclusion Clinical efficacy of both ultrasound-guided percutaneous microwave ablation and CT ultrasound-guided radiofrequency ablation are significant in treating primary liver cancer. Radiofrequency ablation has more advantages in operation time, length of stay, duration of ablation and 3-year recurrence rate.
出处 《中国CT和MRI杂志》 2017年第1期76-78,82,共4页 Chinese Journal of CT and MRI
关键词 原发性肝癌 经皮微波消融 超声引导 肿瘤射频消融 CT Primary Liver Cancer Percutaneous Microwave Ablation Ultrasoundguided Radiofrequency Ablation CT
作者简介 通讯作者:李丽珍
  • 相关文献

参考文献8

二级参考文献84

  • 1原发性肝癌的临床诊断与分期标准[J].肝脏,2004,9(S1):67-68. 被引量:52
  • 2吕明德,徐辉雄,匡铭,谢晓燕,刘广健,徐作峰,郑艳玲,梁瑾瑜.改进微波消融技术治疗肝癌的研究[J].中国实用外科杂志,2004,24(11):678-680. 被引量:27
  • 3陈敏山,李锦清,梁惠宏,林小军,郭荣平,郑云,张亚奇.经皮射频消融与手术切除治疗小肝癌的疗效比较[J].中华医学杂志,2005,85(2):80-83. 被引量:144
  • 4陈敏华,杨薇,严昆,高文,戴莹,王艳滨,霍苓,张晖,黄信孚.应用射频消融法对肝肿瘤患者进行规范化治疗[J].中华医学杂志,2005,85(25):1741-1746. 被引量:70
  • 5Kim YS, Lira HK, Rhim H, et al. Ten-year outcomes of percuta- neous radiofrequency ablation as first-line therapy of early hepato- cellular carcinoma : analysis of prognostic factors [ J ]. J Hepatol, 2013,58 ( 1 ) :89-97.
  • 6Pompili M, Saviano A, de Matthaeis N, et al. Long-term effec- tiveness of resection and radiofrequency ablation for single bepato- cellular carcinoma 3 cm. Results of a muhiccnter Italian survey[ J]. J Hepatol,2013,59 ( 1 ) :89-97.
  • 7Weis S, Franke A, M,ssner J, et al. Radiofrequeney (thermal) ablation versus no intervention or other interventions for hepatocel- lular cm'cinoma[ J]. Cochrane Database Syst Rev, 2013, 12: CD003046.
  • 8Cucchetti A, Piseaglia F, Cescon M, et al. Cost-effectiveness of hepatic resection versus pereutaneous radiofrequeney ablation for early hepatoeellular eareinoma[J]. J Hepatol,2013,59(2):300-307.
  • 9Lee HY, Rhim H, Lee MW, et al. Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency abla- tion: analysis of risk factors[ J]. Eur Radiol,2013,23 ( 1 ) : 190- 197.
  • 10Makino Y, Imai Y, Igura T, et al. Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofre- quency ablation for hepatocellular carcinoma and the correlation to local tumor progression [ J ]. Hepatol Res ,2013,43 ( 9 ) :950-958.

共引文献124

同被引文献348

引证文献48

二级引证文献229

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部